Literature DB >> 27579461

Endophthalmitis caused by Acinetobacter spp. as the presenting manifestation of diabetes mellitus.

Mohammad Mehdi Parvaresh1, Amir Abbas Mehrpouya1, Rahimeh Ganji Anari1, Mohammadreza Aghamirsalim1, Kaveh Abri Aghdam1, Khalil Ghasemi Falavarjani1.   

Abstract

PURPOSE: We describe a patient with endogenous endophthalmitis caused by Acinetobacter spp. as the first clinical presentation of diabetes mellitus.
METHOD: A 48-year-old otherwise healthy woman was referred with signs and symptoms of acute endophthalmitis in the left eye. Systemic work-up, vitreous tap, and intravitreal antibiotic injection were performed followed by pars plana vitrectomy.
RESULTS: The laboratory tests confirmed the diagnosis of diabetes mellitus. Vitreous culture was positive for Acinetobacter spp., and the organism was sensitive to colistin. One month after surgery, vision was no light perception, and the eye was phthisical.
CONCLUSION: Diagnostic work-up should be performed even in otherwise healthy patients with endogenous endophthalmitis.

Entities:  

Keywords:  Acinetobacter species; Diabetes mellitus; Endophthalmitis

Year:  2016        PMID: 27579461      PMCID: PMC4992117          DOI: 10.1016/j.joco.2016.05.005

Source DB:  PubMed          Journal:  J Curr Ophthalmol        ISSN: 2452-2325


Introduction

Endophthalmitis is a sight-threatening ocular condition that usually occurs after surgical procedures or trauma. Endogenous endophthalmitis is less common and occurs when organisms enters the eye by crossing the blood–ocular barrier. Endogenous endophthalmitis is usually associated with systemic risk factors leading to the defects in immune system.1, 2 Diabetes mellitus (DM) is a chronic immune-compromising illness, and several endogenous endophthalmitis cases have been reported in diabetic patients3, 4, 5; however, endogenous endophthalmitis as the presenting manifestation of DM is extremely rare. Moreover, endogenous endophthalmitis caused by Acinetobacter spp. has been rarely reported.7, 8 Here, we report a patient with endogenous endophthalmitis caused by Acinetobacter spp. as the first clinical presentation of DM.

Case report

A 48-year-old female patient was referred with pain, redness, and decreased vision in her left eye during the previous four days. Oral prednisone 50 mg/day had been prescribed by the referring ophthalmologist without improvement in clinical symptoms. At presentation, vision was 10/10 in the right eye and hand movements in her left eye. Slit lamp biomicroscopy examination revealed normal anterior segment and mild scattered dot and blot retinal hemorrhages in the right eye. The cornea showed diffuse stromal haze without keratic precipitates. The anterior chamber demonstrated a hypopyon, and fibrin membrane was noted on the anterior surface of the crystalline lens in the left eye. Moreover, the fundus in the left eye was invisible. Ultrasound examination revealed dense vitreous opacities with an attached retina. She had no previous history of ocular and systemic diseases, trauma, or chronic medication use. There were no signs of sepsis like fever, chills, or loss of appetite. She was admitted with impression of endogenous endophthalmitis, and then vitreous tap and intravitreal injection of vancomycin/ceftazidime were performed. Laboratory examination revealed fasting blood sugar: 280, mg/dl, random blood glucose: 500 mg/dl, and hemoglobin A1C: 9.1. Other endocrinologic and rheumatologic evaluations were unremarkable. No specific site of infection was found by the infectious diseases specialist. The results of chest X-ray and computed tomography (CT) scan of the paranasal sinuses were unremarkable. Blood, urine, and stool cultures were negative. The next day, no improvement occurred in the patient's clinical signs and symptoms. Pars plana vitrectomy without endotamponade was performed. The vitreous cavity was filled with pus. Intravitreal injection of vancomycin/ceftazidime was repeated at the end of vitrectomy. Vitreous culture was positive for Acinetobacter spp., and the organism was resistant to ciprofloxacin, amikacin, gentamicin and ceftazidime, imipenem, and piperacillin-tazobactam and was sensitive only to colistin. The patient received intravenously 1 g ceftazidime two times a day and 500 mg vancomycin three times a day for three days. At the first postoperative day, the symptoms improved, the visual acuity was light perception, and the anterior chamber was clear; however, severe vitritis was still present. Vitreous reaction improved during the next days. One month later, vision was no light perception, and the eye was phthisical.

Discussion

Our patient was not aware of her systemic disease, and the DM was detected by the laboratory tests. The patient took oral prednisolone, and this could raise the blood sugar levels; however, the patient's right eye had findings consistent with non-proliferative diabetic retinopathy. Ko et al reported a case of bilateral endogenous endophthalmitis in a 55-year-old man without history of systemic disease that DM was detected via systemic work-up. In addition, urinary infection was found, and blood culture was positive for Staphylococcus aureus. Ocular and urinary infections responded to antibiotic therapy; however, Candida albicans was isolated from the culture of aqueous humor, and the patient was treated successfully with oral fluconazole. Acinetobacter spp. are found in the environment, soil, and water and have the ability to colonize almost any surface including the skin, respiratory, and gastrointestinal tracts. There are few reports of post-operative and post-traumatic endophthalmitis caused by Acinetobacter spp., and endogenous endophthalmitis caused by Acinetobacter spp. has rarely been reported.7, 8, 9 Although diabetes mellitus may be considered a risk factor in our patient, most reported cases in previous articles did not have any history of systemic illnesses.7, 8 Previously reported Acinetobacter isolates were from baumannii and calcoaceticus species; however, considering the rare detection of this infection in our hospital and difficulty in differentiation of the species,10, 11, 12 our laboratory did not report the exact species of the organism. Acinetobacter spp. infection is a major concern in the field of infectious diseases because of the rapid development of resistance to antimicrobial agents.10, 11 Acinetobacter spp. are also intrinsically less susceptible to antibiotics than many virulent bacteriae like Enterobacteriaceae. Carbapenems, fluoroquinolones, and doxycycline may have activity against Acinetobacter spp. The most important problem in the treatment of Acinetobacter infection is acquired multi-drug resistance. The mechanism for acquired resistance includes any or all of the following mechanisms: degradation enzymes against β-lactams, modification enzymes against aminoglycosides, altered binding sites for quinolines, and a variety of efflux mechanisms and changes in outer membrane proteins. Recent clinical isolates of Acinetobacter spp. were often found to be multi-resistant to carbapenems, fluoroquinolones, and aminoglycosides. Colistin-resistant isolates are rare, but started to be isolated.11, 12 Our case was resistant to all antibiotics tested except for colistin. Considering adverse consequences of delayed treatment, carbapenems such as Imipenem are often given as a drug of choice for serious Acinetobacter spp. infections. However, given the probability that the organism would be most likely resistant to one of the common first line antibiotics, treatment of the infection should be tailored based on antimicrobial susceptibility testing. In conclusion, diabetes mellitus may rarely be discovered following endogenous endophthalmitis. Even in otherwise healthy patients with endogenous endophthalmitis, a complete diagnostic work-up should be performed.
  13 in total

1.  Bilateral endogenous Candida endophthalmitis as the presenting manifestation of diabetes mellitus.

Authors:  Y C Ko; C J Liu; Y M Chung; W C Tsai
Journal:  Eye (Lond)       Date:  2001-04       Impact factor: 3.775

Review 2.  Endogenous endophthalmitis in the developing world.

Authors:  J Fernando Arevalo; Aliza Jap; Soon-Phaik Chee; David G Zeballos
Journal:  Int Ophthalmol Clin       Date:  2010

3.  Risk factors for endogenous endophthalmitis secondary to klebsiella pneumoniae liver abscess: 20-year experience in Southern Taiwan.

Authors:  Shwu-Jiuan Sheu; Ya-Hsin Kung; Tsung-Tien Wu; Fang-Ping Chang; Yu-Harn Horng
Journal:  Retina       Date:  2011-11       Impact factor: 4.256

4.  Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study.

Authors:  A A Okada; R P Johnson; W C Liles; D J D'Amico; A S Baker
Journal:  Ophthalmology       Date:  1994-05       Impact factor: 12.079

5.  Endophthalmitis caused by Acinetobacter calcoaceticus. A profile.

Authors:  Lingam Gopal; Anand A Ramaswamy; Hajib N Madhavan; Rajani R Battu; Tarun Sharma; Mahesh P Shanmugam; Pramod S Bhende; Muna Bhende; Dhanashree Ratra; Nitin S Shetty; Madhav K Rao
Journal:  Indian J Ophthalmol       Date:  2003-12       Impact factor: 1.848

Review 6.  Group B Streptococcus endogenous endophthalmitis : case reports and review of the literature.

Authors:  Shu-Yen Lee; Soon-Phaik Chee
Journal:  Ophthalmology       Date:  2002-10       Impact factor: 12.079

7.  Endophthalmitis caused by Acinetobacter baumannii: report of two cases.

Authors:  Kuan-Jen Chen; Chiun-Ho Hou; Ming-Hui Sun; Chi-Chun Lai; Chi-Chin Sun; Ching-Hsi Hsiao
Journal:  J Clin Microbiol       Date:  2008-01-09       Impact factor: 5.948

Review 8.  Acinetobacter baumannii: an emerging opportunistic pathogen.

Authors:  Aoife Howard; Michael O'Donoghue; Audrey Feeney; Roy D Sleator
Journal:  Virulence       Date:  2012-05-01       Impact factor: 5.882

Review 9.  Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens.

Authors:  Kyungwon Lee; Dongeun Yong; Seok Hoon Jeong; Yunsop Chong
Journal:  Yonsei Med J       Date:  2011-11       Impact factor: 2.759

10.  Isolates and antibiotic resistance of culture-proven endophthalmitis cases presented to a referral center in Tehran.

Authors:  Khalil Ghasemi Falavarjani; Shahbaz Nekoozadeh; Mehdi Modarres; Mohammad M Parvaresh; Masih Hashemi; Reza Soodi; Sayyed Amirpooya Alemzadeh
Journal:  Middle East Afr J Ophthalmol       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.